Clinical trial
HbA1c Variability in Type II Diabetes
NCT02879409
Study timeline
Study start (unknown)2016-11-01Date precision: month
Registry last updated2025-07-20
Observed by CureCurrent2026-10-07
Recorded dates are source observations, not predictions. Missing milestones are not estimated.
Conditions
Diabetes Mellitus Type 2unresolved
Interventions
MetforminDRUG · verified · RxNorm: metformin
GliclazideDRUG
SitagliptinDRUG · verified · RxNorm: sitagliptin
LiraglutideDRUG · verified · RxNorm: liraglutide
PioglitazoneDRUG · verified · RxNorm: pioglitazone
DapagliflozinDRUG · verified · RxNorm: dapagliflozin
human insulinDRUG
Sponsors & collaborators
Weill Cornell Medical College in Qatarlead sponsor
Hamad Medical Corporationcollaborator
Sidra Medicinecollaborator
University of Hullcollaborator
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT02879409 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.